<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6996547/results/search/disease/results.xml">
  <result pre="Husbandry Industry Co., LtdBeijingPeople’s Republic of China[3], National Institute for" exact="Viral" post="Disease Control and Prevention, Collaboration Innovation Center for Diagnosis"/>
  <result pre="Industry Co., LtdBeijingPeople’s Republic of China[3], National Institute for Viral" exact="Disease" post="Control and Prevention, Collaboration Innovation Center for Diagnosis and"/>
  <result pre="and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of" exact="Infectious" post="Diseases, Chinese Center for Disease Control and Prevention, Key"/>
  <result pre="for Diagnosis and Treatment of Infectious Diseases, Chinese Center for" exact="Disease" post="Control and Prevention, Key Laboratory for Medical Virology, National"/>
  <result pre="Abstract Background New approaches are urgently needed to fight influenza" exact="viral infection." post="Previous research has shown that zirconia nanoparticles can be"/>
  <result pre="effect of zirconia (ZrO2) nanoparticles (NPs) against a highly pathogenic" exact="avian influenza" post="virus. Materials and Methods In this study, the antiviral"/>
  <result pre="using zirconia NPs shows protection of mice against highly pathogenic" exact="avian influenza" post="virus and suggests strong application potential for this method,"/>
  <result pre="new tool against a wide range of microbial infections. Keywords" exact="avian influenza" post="virus zirconia nanoparticles cytokine storm antiviral effect fig-count: ref-count:"/>
  <result pre="page-count: Introduction In recent years, a large number of rapidly-spreading" exact="viral" post="outbreaks have placed considerable demands on healthcare infrastructure, sparking"/>
  <result pre="on healthcare infrastructure, sparking global concern.1,2 The emergence of severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) in 2002,3 the H1N1 influenza"/>
  <result pre="healthcare infrastructure, sparking global concern.1,2 The emergence of severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) in 2002,3 the H1N1 influenza pandemic"/>
  <result pre="infrastructure, sparking global concern.1,2 The emergence of severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) in 2002,3 the H1N1 influenza pandemic in"/>
  <result pre="2015 illustrate the severity of these outbreaks.8,9 Among these viruses," exact="avian influenza" post="virus H5N1 has attracted a great deal of attention"/>
  <result pre="worldwide.10,11 The leading cause of death in infected patients is" exact="diffuse" post="alveolar damage and hemorrhage in the lungs, which is"/>
  <result pre="easy-to-use detection method as well as a promising adjuvant against" exact="viral" post="infections due to their unique physical and chemical characteristics"/>
  <result pre="detection method as well as a promising adjuvant against viral" exact="infections" post="due to their unique physical and chemical characteristics and"/>
  <result pre="and composition for NP-mediated protection of animals from highly pathogenic" exact="avian influenza" post="virus H5N1 infection. The results showed that ZrO2 with"/>
  <result pre="optimal physical and chemical characteristics could reduce mouse mortality, alleviate" exact="respiratory" post="pathological changes, and inhibit viral replication in the lungs"/>
  <result pre="could reduce mouse mortality, alleviate respiratory pathological changes, and inhibit" exact="viral" post="replication in the lungs of H5N1-infected mice. Treatment with"/>
  <result pre="lungs of H5N1-infected mice. Treatment with ZrO2 prior to influenza" exact="infection" post="caused prompt initiation of the host antiviral response and"/>
  <result pre="method for the protection of humans or animals against various" exact="viral" post="infections. Materials and Methods Animals Six–Seven-weeks-old female BALB/c mice"/>
  <result pre="animals against various viral infections. Materials and Methods Animals Six–Seven-weeks-old" exact="female" post="BALB/c mice were purchased from Vital River Laboratories (Beijing,"/>
  <result pre="being used, the particle suspensions were dispersed by sonification. The" exact="morphology" post="and structure of NPs were observed with a JEOL-200CX"/>
  <result pre="3000HSA particle analyzer (Malvern Company,UK) at 25°C. Intraperitoneal Administration and" exact="Viral" post="Challenge The nanomaterial or glucose was administered intraperitoneally to"/>
  <result pre="one day apart. On the second day of administration, the" exact="viral" post="challenge was given. The H5N1 influenza virus (A/chicken/Henan/1/2004) used"/>
  <result pre="neutral formalin at room temperature for 48 h. Histopathological and" exact="viral" post="antigen analyses of lung tissues on day 6 post-infection"/>
  <result pre="veterinary pathologist and scored from 0 to 4 in a" exact="blind" post="study. Descriptions of the lung scores were as follows:"/>
  <result pre="mild, characterized by mild interstitial edema and desquamation of rare" exact="epithelial" post="cells; 2 = mild, characterized by interstitial edema, thickening"/>
  <result pre="QPCR and ELISA analyses were conducted as previously described.38 Briefly," exact="total" post="RNA was extracted from approximately 10 mg of lung"/>
  <result pre="a standard. The expression levels of interferon (IFN)-α, IFN-β, IFN-γ," exact="monocyte" post="chemoattractant protein (MCP)-1, interleukin (IL)-1β, IL-6, IL-12, interferon-induced protein"/>
  <result pre="protein (MCP)-1, interleukin (IL)-1β, IL-6, IL-12, interferon-induced protein (IP)-10, and" exact="tumor" post="necrosis factor (TNF)-α were measured using the relative quantification"/>
  <result pre="with 1% crystal violet. Plaque-forming units (PFUs) were then counted." exact="Dendritic Cell" post="(DC) Surface Staining for Co-Stimulatory Molecules Fluorescent conjugated rat"/>
  <result pre="with 4% paraformaldehyde and permeabilized with 0.1% saponin (Sigma-Aldrich) for" exact="complete" post="intracellular staining. Cells were then double-stained with antibodies for"/>
  <result pre="0.05 were considered representative of statistically significant differences. Results ZrO2" exact="Increased" post="Survival of H5N1-Infected Mice To study the protective effects"/>
  <result pre="To study the protective effects of NPs in IAV H5N1" exact="infection" post="in vivo, three kinds of NPs, namely ZrO2, SNs,"/>
  <result pre="apart. On the day of the second NP administration, the" exact="viral" post="challenge was given with triple LD50 of H5N1, and"/>
  <result pre="day apart. On the second day of NP administration, the" exact="viral" post="challenge was administered, with triple the LD50 of H5N1."/>
  <result pre="NPs. To explore whether the effect of NPs against H5N1" exact="infection" post="was dose-dependent, an experiment was performed using ZrO2, SNs,"/>
  <result pre="100 mg/kg could improve the survival of H5N1-infected mice. ZrO2" exact="Reduced" post="Lung Injury and Viral Replication in H5N1-Infected Mice To"/>
  <result pre="the survival of H5N1-infected mice. ZrO2 Reduced Lung Injury and" exact="Viral" post="Replication in H5N1-Infected Mice To further investigate whether ZrO2"/>
  <result pre="H5N1-Infected Mice To further investigate whether ZrO2 could affect H5N1" exact="virus infection," post="BALB/c mice received a dose of triple the LD50"/>
  <result pre="alveolar lumen filled with edema ﬂuid mixed with exfoliated alveolar" exact="epithelial" post="cells, erythrocytes, and inﬂammatory cells was also observed in"/>
  <result pre="lung tissue, inflammatory cell infiltration was observed in the small" exact="blood vessels" post="and bronchi. The lung tissues from mice in the"/>
  <result pre="Positively-charged ZrO2 NPs of 200 nm reduced lung injury and" exact="viral" post="replication in H5N1-infected mice. (A) Representative lung sections from"/>
  <result pre="group were stained with H&amp;amp;E (400×) and scored in a" exact="blind" post="study. The black triangles show alveolar lumen ﬂooded with"/>
  <result pre="lumen ﬂooded with edema ﬂuid and mixed with exfoliated alveolar" exact="epithelial" post="cells, inﬂammatory cells, and erythrocytes. Arrows represent interstitial edema"/>
  <result pre="Arrows represent interstitial edema and inﬂammatory cellular inﬁltration around small" exact="blood vessels" post="and bronchioles. Empty triangles indicate reduction in the number"/>
  <result pre="bronchioles. Empty triangles indicate reduction in the number of mucous" exact="epithelial" post="cells in bronchioles. (B) Representative lung sections from each"/>
  <result pre="group were stained using IHC (400×) and scored in a" exact="blind" post="study. Arrows indicate positive cells. (C) Expression levels of"/>
  <result pre="influence of ZrO2 on replication of IAV in vivo, the" exact="viral" post="load in the lung tissues of virus-infected mice was"/>
  <result pre="values in the ZrO2 groups at day 6 post-infection were" exact="lower" post="than those of glucose-treated mice, with the 100 mg/kg"/>
  <result pre="significant difference (P &amp;lt; 0.05). At day 6 post-infection, the" exact="pulmonary" post="viral titers of ZrO2 groups were significantly lower than"/>
  <result pre="difference (P &amp;lt; 0.05). At day 6 post-infection, the pulmonary" exact="viral" post="titers of ZrO2 groups were significantly lower than those"/>
  <result pre="post-infection, the pulmonary viral titers of ZrO2 groups were significantly" exact="lower" post="than those of glucose-treated mice, with extremely significant differences"/>
  <result pre="ZrO2 and 100 mg/kg ZrO2 groups (P &amp;lt; 0.001). These" exact="viral" post="titer results were in accordance with the results of"/>
  <result pre="of IHC staining. Taken together, ZrO2 reduces lung injury and" exact="viral" post="replication in H5N1-infected mice. ZrO2 Enhanced the Innate Immunity"/>
  <result pre="we found that the higher dosage of ZrO2 resulted in" exact="lower" post="expression, which was due to toxicity of ZrO2 in"/>
  <result pre="enhances innate immunity in mice. ZrO2 Reduces the Overexpression of" exact="Inflammatory" post="Cytokines in H5N1-Infected Mice For mechanistic analysis, we evaluated"/>
  <result pre="and those in the 100 mg/kg ZrO2 group showed significantly" exact="lower" post="expression levels (P &amp;lt; 0.05). Combined with histopathological analyses"/>
  <result pre="ZrO2 group showed significantly lower expression levels (P &amp;lt; 0.05)." exact="Combined" post="with histopathological analyses and the detection of HA copy"/>
  <result pre="results confirm that NPs can alleviate pathological injury and reduce" exact="viral" post="levels in the lungs through degradation of the cytokine"/>
  <result pre="storm occurs when excessive levels of pro-inflammatory cytokines induce an" exact="acute" post="mononuclear and neutrophilic inflammatory response.44 ELISA results also showed"/>
  <result pre="mononuclear and neutrophilic inflammatory response.44 ELISA results also showed significantly" exact="lower" post="protein expression levels of cytokines in the 100 mg/kg"/>
  <result pre="involved in the cytokine storm and consequently protect animals from" exact="viral infection." post="Figure 5 Positively-charged ZrO2 NPs of 200 nm suppressed"/>
  <result pre="Discussions Influenza A virus is one of the most common" exact="respiratory" post="pathogens worldwide. In 1997, the ﬁrst major epidemic of"/>
  <result pre="worldwide. In 1997, the ﬁrst major epidemic of highly pathogenic" exact="avian influenza" post="virus H5N1 occurred in Hong Kong. Since then, it"/>
  <result pre="To date, it has been classified as a List A" exact="disease" post="by the World Organisation for Animal Health (OIE) and"/>
  <result pre="for Animal Health (OIE) and as a Category 1 animal" exact="disease" post="in China. A variety of antiviral drugs and vaccines"/>
  <result pre="viruses due to their highly contagious nature, frequent mutation of" exact="viral" post="genes, and the emergence of resistant influenza strains due"/>
  <result pre="abuse of antiviral drugs. Therefore, new approaches to fighting influenza" exact="virus infection" post="are urgently needed. Due to unique structure and chemical"/>
  <result pre="of antiviral drugs. Therefore, new approaches to fighting influenza virus" exact="infection" post="are urgently needed. Due to unique structure and chemical"/>
  <result pre="anti-tumor drugs, NPs can significantly improve the curative effects of" exact="tumor" post="therapies and reduce toxic drug side effects, making them"/>
  <result pre="reduce toxic drug side effects, making them attractive candidates for" exact="cancer" post="therapy.47,48 For anti-viral therapy, NPs can be used as"/>
  <result pre="reported. Herein, we have demonstrated that NPs alone effectively inhibit" exact="viral" post="replication in a mouse model and protect mice from"/>
  <result pre="to control influenza infection. H5N1 influenza virus can cause severe" exact="respiratory" post="diseases in humans and mammals. The clinical symptoms include"/>
  <result pre="diseases in humans and mammals. The clinical symptoms include fever," exact="muscle" post="aches, cough, headache, diarrhea, viral pneumonia, encephalitis, and acute"/>
  <result pre="The clinical symptoms include fever, muscle aches, cough, headache, diarrhea," exact="viral pneumonia," post="encephalitis, and acute respiratory distress syndrome (ARDS).50 In the"/>
  <result pre="fever, muscle aches, cough, headache, diarrhea, viral pneumonia, encephalitis, and" exact="acute respiratory distress syndrome" post="(ARDS).50 In the mouse model, it can cause hair"/>
  <result pre="muscle aches, cough, headache, diarrhea, viral pneumonia, encephalitis, and acute" exact="respiratory" post="distress syndrome (ARDS).50 In the mouse model, it can"/>
  <result pre="cough, headache, diarrhea, viral pneumonia, encephalitis, and acute respiratory distress" exact="syndrome" post="(ARDS).50 In the mouse model, it can cause hair"/>
  <result pre="(ARDS).50 In the mouse model, it can cause hair thickening," exact="bowed" post="limbs, blindness, trembling, significant weight loss, severe pathological tissue"/>
  <result pre="changes, and even death.51 Previous studies have shown that virus-induced" exact="acute" post="lung injury or ARDS is triggered by a cytokine"/>
  <result pre="immune cells to the infected area.52 Excessive inflammation can cause" exact="systemic" post="inflammatory response syndrome, during which the body enters a"/>
  <result pre="appears to be more effective in protection when compared to" exact="lower" post="doses. Previous researches by our team have researched the"/>
  <result pre="lower doses. Previous researches by our team have researched the" exact="systemic" post="toxicity of ZrO2 NPs and demonstrated that dosages of"/>
  <result pre="we consider that this clinical phenomenon may lead to the" exact="lower" post="expression of immune indicators in spleen of the 100"/>
  <result pre="ZrO2 NPs can be carried into lung most effectively after" exact="viral infection" post="when compared to 25 mg/kg ZrO2 NPs and 50"/>
  <result pre="NPs can be carried into lung most effectively after viral" exact="infection" post="when compared to 25 mg/kg ZrO2 NPs and 50"/>
  <result pre="nm size and 100 mg/kg dose conferred protection against H5N1" exact="infection" post="in mice (Figure 6). The mechanisms of this protection"/>
  <result pre="stage of H5N1 infection. Appropriate NP treatment could reduce the" exact="viral" post="load and suppress the inflammatory cytokine storm in the"/>
  <result pre="nm size and 100 mg/kg dose conferred protection against H5N1" exact="infection" post="in mice. The mechanisms are related to ZrO2-mediated enhancement"/>
  <result pre="stage of H5N1 infection. The appropriate nanoparticle treatment could reduce" exact="viral" post="load and suppress the inflammatory cytokine storm in the"/>
  <result pre="H5N1-infected mice and alleviate lung injury. ZrO2 NPs reduce the" exact="viral" post="load and suppress the inflammatory storm in H5N1- infected"/>
  <result pre="HammondJM, PintoJ, PerezAM. Review of the global distribution of foot-and-mouth" exact="disease" post="virus from 2007 to 2014. Transbound Emerg Dis. 2017;64(2):316–332."/>
  <result pre="LiuJ, WuJ, ZhongE. Understanding the spatial diffusion process of severe" exact="acute" post="respiratory syndrome in Beijing. Public Health. 2005;119(12):1080–1087. doi:10.1016/j.puhe.2005.02.00316214187 4.ThomasM,"/>
  <result pre="WuJ, ZhongE. Understanding the spatial diffusion process of severe acute" exact="respiratory" post="syndrome in Beijing. Public Health. 2005;119(12):1080–1087. doi:10.1016/j.puhe.2005.02.00316214187 4.ThomasM, ManiRS,"/>
  <result pre="ZhongE. Understanding the spatial diffusion process of severe acute respiratory" exact="syndrome" post="in Beijing. Public Health. 2005;119(12):1080–1087. doi:10.1016/j.puhe.2005.02.00316214187 4.ThomasM, ManiRS, PhilipM,"/>
  <result pre="chemokines are major mediators of exuberant immune response associated with" exact="Influenza A (H1N1)" post="pdm09 virus infection. J Med Virol. 2017;89(8):1373–1381. doi:10.1002/jmv.2478128198028 5.YuY,"/>
  <result pre="of exuberant immune response associated with Influenza A (H1N1) pdm09" exact="virus infection." post="J Med Virol. 2017;89(8):1373–1381. doi:10.1002/jmv.2478128198028 5.YuY, ZhangZ, LiH, et"/>
  <result pre="doi:10.1002/jmv.2478128198028 5.YuY, ZhangZ, LiH, et al. Biological characterizations of H5Nx" exact="avian influenza" post="viruses embodying different neuraminidases. Front Microbiol. 2017;8:1084. doi:10.3389/fmicb.2017.0108428659898 6.GonzalesJL,"/>
  <result pre="BoumaA, KochG, de WitJJ, StegemanJA. Transmission characteristics of low pathogenic" exact="avian influenza" post="virus of H7N7 and H5N7 subtypes in layer chickens."/>
  <result pre="doi:10.1016/j.vetmic.2011.09.01621982127 7.NohJY, YoonSW, KimDJ, et al. Simultaneous detection of severe" exact="acute" post="respiratory syndrome, Middle East respiratory syndrome, and related bat"/>
  <result pre="7.NohJY, YoonSW, KimDJ, et al. Simultaneous detection of severe acute" exact="respiratory" post="syndrome, Middle East respiratory syndrome, and related bat coronaviruses"/>
  <result pre="al. Simultaneous detection of severe acute respiratory syndrome, Middle East" exact="respiratory" post="syndrome, and related bat coronaviruses by real-time reverse transcription"/>
  <result pre="9.BrooksT, Roy-BurmanA, TuholskeC, et al. Real-time evolution of zika virus" exact="disease" post="outbreak, Roatan, Honduras. Emerg Infect Dis. 2017;23(8). doi:10.3201/eid2308.161944 10.Marinova-PetkovaA,"/>
  <result pre="2017;23(8). doi:10.3201/eid2308.161944 10.Marinova-PetkovaA, FranksJ, TenzinS, et al. Highly pathogenic reassortant" exact="avian influenza" post="A(H5N1) Virus Clade 2.3.2.1a in Poultry, Bhutan. Emerg Infect"/>
  <result pre="Environmental contamination and risk factors for transmission of highly pathogenic" exact="avian influenza" post="A(H5N1) to humans, Cambodia, 2006–2010. BMC Infect Dis. 2016;16(1):631."/>
  <result pre="Quantified degree of poultry exposure differs for human cases of" exact="avian influenza" post="H5N1 and H7N9. Epidemiol Infect. 2016;144(12):2633–2640. doi:10.1017/S095026881600103527267621 14.Dae YoungK,"/>
  <result pre="Theory Eng. 2015;7(2):145–148. doi:10.7763/IJCTE.2015.V7.946 15.BurggraafS, KarpalaAJ, BinghamJ, et al. H5N1" exact="infection" post="causes rapid mortality and high cytokine levels in chickens"/>
  <result pre="J Infect Dis. 2015;211(2):249–257. doi:10.1093/infdis/jiu44725124927 18.WuY, GaoF, QiJ, et al." exact="Resistance" post="to mutant group 2 influenza virus neuraminidases of an"/>
  <result pre="ZhangS, YuY, ZhangH, HeQ. Structural-engineering rationales of gold nanoparticles for" exact="cancer" post="theranostics. Adv Mat. 2016;28(39):8567–8585. doi:10.1002/adma.201602080 22.MoonJJ, HuangB, IrvineDJ. Engineering"/>
  <result pre="doi:10.1021/acsnano.5b0802526844372 27.ZhuG, ZhangF, NiQ, NiuG, ChenX. Efficient nanovaccine delivery in" exact="cancer" post="immunotherapy. ACS Nano. 2017;11(3):2387–2392. doi:10.1021/acsnano.7b0097828277646 28.SunB, JiZ, LiaoYP, et"/>
  <result pre="influenza virus. J Virol. 2012;86(6):3347–3356. doi:10.1128/JVI.06053-1122238293 37.JinY, HuY, HanD, WangM." exact="Chronic" post="heat stress weakened the innate immunity and increased the"/>
  <result pre="the innate immunity and increased the virulence of highly pathogenic" exact="avian influenza" post="virus H5N1 in mice. J Biomed Biotechnol. 2011;2011:367846. doi:10.1155/2011/36784621687549"/>
  <result pre="of CdSe quantum dot size, surface charge, and functionalization on" exact="primary" post="human lung cells. ACS Nano. 2012;6(6):4748–4762. doi:10.1021/nn204886b22587339 41.MengH, XueM,"/>
  <result pre="effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft" exact="tumor" post="model. ACS Nano. 2011;5(5):4131–4144. doi:10.1021/nn200809t21524062 42.LuK, DongS, PetersenEJ, et"/>
  <result pre="al. Biological uptake, distribution, and depuration of radio-labeled graphene in" exact="adult" post="zebrafish: effects of graphene size and natural organic matter."/>
  <result pre="of immunomodulatory therapy. Cell Mol Immunol. 2016;13(1):3–10. doi:10.1038/cmi.2015.7426189369 45.UyekiTM. Human" exact="infection" post="with highly pathogenic avian influenza A (H5N1) virus: review"/>
  <result pre="Mol Immunol. 2016;13(1):3–10. doi:10.1038/cmi.2015.7426189369 45.UyekiTM. Human infection with highly pathogenic" exact="avian influenza" post="A (H5N1) virus: review of clinical issues. Clin Infect"/>
  <result pre="WangM, et al. Influenza a viruses replicate productively in mouse" exact="mastocytoma" post="cells (P815) and trigger pro-inflammatory cytokine and chemokine production"/>
  <result pre="silica through a general and facile pre-shell-post-core process for simultaneous" exact="cancer" post="imaging and therapy. Chem Commun. 2013;49(72):7902–7904. doi:10.1039/c3cc43660h 48.LiL, TangF,"/>
  <result pre="al. In vivo delivery of silica nanorattle encapsulated docetaxel for" exact="liver cancer" post="therapy with low toxicity and high efficacy. ACS Nano."/>
  <result pre="In vivo delivery of silica nanorattle encapsulated docetaxel for liver" exact="cancer" post="therapy with low toxicity and high efficacy. ACS Nano."/>
  <result pre="outcome of human influenza A (H5N1) is associated with high" exact="viral" post="load and hypercytokinemia. Nat Med. 2006;12(10):1203–1207. doi:10.1038/nm147716964257 53.CheungCY, PoonLL,"/>
 </snippets>
</snippetsTree>
